Iwanaga, E., Nanri, T., Matsuno, N., Kawakita, T., Mitsuya, H. and Asou, N. (2009) “A JAK2-V617F activating mutation in addition to KIT and FLT3 mutations is associated with clinical outcome in patients with t(8;21)(q22;q22) acute myeloid leukemia”, Haematologica. Pavia, Italy, 94(3), pp. 433-435. doi: 10.3324/haematol.13283.